Ethical and Regulatory Concerns in Pragmatic Clinical Trial Monitoring and Oversight
Ethics & Human Research · 2020-09 · 42 (5) · 29-37
DOI: 10.1002/eahr.500066 ↗Kurz gefasst
Pragmatische Studie in der Zeitschrift Ethics & Human Research, online erschienen am 16.09.2020. Verfasst von Michelle K Roberts und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research coordinator of rehabilitation medicine at the University of Washington School of Medicine. Hauptthemen laut MEDLINE: Ethics, Research, Government Regulation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: NCCIH NIH HHS, National Institutes of Health (NIH) Common Fund, National Institutes of Health.
Abstract (Originalsprache)
The implementation of pragmatic clinical trials (PCTs) can be accompanied by unique regulatory challenges. In this paper, we describe the experience and management of regulatory noncompliance during a 25‐site acute care PCT. During the trial, the study team conducted a comprehensive audit of all enrollment forms (informed consent and Health Insurance Portability and Accountability Act authorization forms) and related study documentation. A review of 997 participants’ enrollment forms identified 138 (13.8%) that required reporting to the institutional review board due to noncompliance. To prevent subsequent noncompliance, the study team developed and introduced a revised participant tracking system, reviewed all enrollment documentation, and retrained sites regarding study procedures. Based on these experiences, we developed a set of recommendations for future PCTs to ensure both operational success and regulatory compliance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research coordinator of rehabilitation medicine at the University of Washington School of Medicine.
- Research study coordinator of psychiatry and behavioral sciences at the University of Washington School of Medicine.
- Doctoral student in the Department of Psychology at Drexel University.
- Assistant professor of psychiatry and behavioral sciences at the University of Washington School of Medicine.
- Harvey M. Meyerhoff Professor of Bioethics and Medicine at the Berman Institute of Bioethics and at the School of Medicine at Johns Hopkins University.
- Director of regulatory affairs at Advarra.
Förderung
- NCCIH NIH HHS
- National Institutes of Health (NIH) Common Fund
- National Institutes of Health
Zitieren
APA
Roberts, M. K., Fisher, D. M., Parker, L. E., Darnell, D., Sugarman, J., Carrithers, J., Weinfurt, K., Jurkovich, G., & Zatzick, D. (2020). Ethical and Regulatory Concerns in Pragmatic Clinical Trial Monitoring and Oversight. Ethics & Human Research, 42(5), 29-37. https://doi.org/10.1002/eahr.500066
Vancouver
Roberts MK, Fisher DM, Parker LE, Darnell D, Sugarman J, Carrithers J, et al. Ethical and Regulatory Concerns in Pragmatic Clinical Trial Monitoring and Oversight. Ethics & Human Research. 2020;42(5):29-37. doi:10.1002/eahr.500066
BibTeX
@article{Roberts2020,
author = {Roberts, Michelle K and Fisher, Dylan M and Parker, Lea E and Darnell, Doyanne and Sugarman, Jeremy and Carrithers, Judith and Weinfurt, Kevin and Jurkovich, Gregory and Zatzick, Douglas},
title = {Ethical and Regulatory Concerns in Pragmatic Clinical Trial Monitoring and Oversight},
journal = {Ethics & Human Research},
year = {2020},
volume = {42},
number = {5},
pages = {29--37},
doi = {10.1002/eahr.500066}
}
EUVIMED